Nanoform Finland Oy

  • FI
  • 2019
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Other
Contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from Nanoform Finland Oy (4)

  • AI Drug Candidate Screening

    Product AI Drug Candidate Screening

    Our STARMAP® 2.0 platform leverages cutting-edge sparse-data AI to pick winners among candidate molecules that are predicted to be best amenable to CESS®-powered nanoforming and that exhibit optimal production characteristics.

    When existing data alone is not sufficient for generating specific pr...
  • Biologics

    Product Biologics

    Why have we developed our bio nanoparticle technology?

    The biologics industry is expanding rapidly as the potential of biological therapies grows in recognition. The field is also expected to become more versatile as it grows from antibody-focused production to gene and cell therapies, exosomes,...
  • Formulations

    Product Formulations

    We understand that speed is of the essence when working to deliver a life-changing drug to market. Our experienced clinical formulation development team can support formulation development across a vast range of dosage forms – including oral, ophthalmic and transdermal formulations, as well as injectables,...
  • Small Molecules

    Product Small Molecules

    Our multi-patented Controlled Expansion of Supercritical Solutions (CESS®) technology enables the creation of API nanoparticles directly from solution. The process can be applied to most small molecules, with a high success rate of 80-90%.

    CESS® is a bottom-up method of recrystallization that wo...

Nanoform Finland Oy Resources (1)

  • Brochure Nanoform brochure

    NanoImprove the Performance of Your Formulations Small and Large Molecule Formulations Across the Product Life Cycle.NanoImprove Small Molecules
    NanoImprove Large Molecules
    NanoImprove the Performance of Your BioFormulations With NanoParticles by Design
    Nanoforming Success Accelerated by Proprietary AI Technology STARMAP® Drives Predictions of NanoImprovement Success